Table of Content

1 Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Market Definition and Overview
1.1 Objectives of the Study
1.2 Overview of Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx)
1.3 Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Market Scope and Market Size Estimation
1.4 Market Segmentation
1.4.1 Types of Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx)
1.4.2 Applications of Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx)
1.5 Market Exchange Rate

2 Research Method and Logic
2.1 Methodology
2.2 Research Data Source

3 Market Competition Analysis
3.1 Qiagen NV Market Performance Analysis
3.1.1 Qiagen NV Basic Information
3.1.2 Product and Service Analysis
3.1.3 Strategies for Company to Deal with the Impact of COVID-19
3.1.4 Qiagen NV Sales, Value, Price, Gross Margin 2016-2021
3.2 Pfizer Market Performance Analysis
3.2.1 Pfizer Basic Information
3.2.2 Product and Service Analysis
3.2.3 Strategies for Company to Deal with the Impact of COVID-19
3.2.4 Pfizer Sales, Value, Price, Gross Margin 2016-2021
3.3 Thermo Fisher Scientific Inc. Market Performance Analysis
3.3.1 Thermo Fisher Scientific Inc. Basic Information
3.3.2 Product and Service Analysis
3.3.3 Strategies for Company to Deal with the Impact of COVID-19
3.3.4 Thermo Fisher Scientific Inc. Sales, Value, Price, Gross Margin 2016-2021
3.4 Agilent Technologies Market Performance Analysis
3.4.1 Agilent Technologies Basic Information
3.4.2 Product and Service Analysis
3.4.3 Strategies for Company to Deal with the Impact of COVID-19
3.4.4 Agilent Technologies Sales, Value, Price, Gross Margin 2016-2021
3.5 Foundation Medicine Market Performance Analysis
3.5.1 Foundation Medicine Basic Information
3.5.2 Product and Service Analysis
3.5.3 Strategies for Company to Deal with the Impact of COVID-19
3.5.4 Foundation Medicine Sales, Value, Price, Gross Margin 2016-2021
3.6 F Hoffman La Roche Market Performance Analysis
3.6.1 F Hoffman La Roche Basic Information
3.6.2 Product and Service Analysis
3.6.3 Strategies for Company to Deal with the Impact of COVID-19
3.6.4 F Hoffman La Roche Sales, Value, Price, Gross Margin 2016-2021
3.7 GE Healthcare Market Performance Analysis
3.7.1 GE Healthcare Basic Information
3.7.2 Product and Service Analysis
3.7.3 Strategies for Company to Deal with the Impact of COVID-19
3.7.4 GE Healthcare Sales, Value, Price, Gross Margin 2016-2021
3.8 Leica Biosystems Nussloch GmBH Market Performance Analysis
3.8.1 Leica Biosystems Nussloch GmBH Basic Information
3.8.2 Product and Service Analysis
3.8.3 Strategies for Company to Deal with the Impact of COVID-19
3.8.4 Leica Biosystems Nussloch GmBH Sales, Value, Price, Gross Margin 2016-2021

4 Market Segment by Type, Historical Data and Market Forecasts
4.1 Global Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Production and Value by Type
4.1.1 Global Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Production by Type 2016-2021
4.1.2 Global Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Market Value by Type 2016-2021
4.2 Global Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Market Production, Value and Growth Rate by Type 2016-2021
4.2.1 PCR Market Production, Value and Growth Rate
4.2.2 In-situ Hybridization Market Production, Value and Growth Rate
4.2.3 Immunohistochemistry Market Production, Value and Growth Rate
4.2.4 Sequencing Market Production, Value and Growth Rate
4.2.5 Others Market Production, Value and Growth Rate
4.3 Global Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Production and Value Forecast by Type
4.3.1 Global Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Production Forecast by Type 2021-2026
4.3.2 Global Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Market Value Forecast by Type 2021-2026
4.4 Global Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Market Production, Value and Growth Rate by Type Forecast 2021-2026
4.4.1 PCR Market Production, Value and Growth Rate Forecast
4.4.2 In-situ Hybridization Market Production, Value and Growth Rate Forecast
4.4.3 Immunohistochemistry Market Production, Value and Growth Rate Forecast
4.4.4 Sequencing Market Production, Value and Growth Rate Forecast
4.4.5 Others Market Production, Value and Growth Rate Forecast

5 Market Segment by Application, Historical Data and Market Forecasts
5.1 Global Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Consumption and Value by Application
5.1.1 Global Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Consumption by Application 2016-2021
5.1.2 Global Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Market Value by Application 2016-2021
5.2 Global Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Market Consumption, Value and Growth Rate by Application 2016-2021
5.2.1 Oncology Market Consumption, Value and Growth Rate
5.2.2 Neurological Disorders Market Consumption, Value and Growth Rate
5.2.3 Cardiovascular Disease Market Consumption, Value and Growth Rate
5.2.4 Immunological Disorders Market Consumption, Value and Growth Rate
5.2.5 Others Market Consumption, Value and Growth Rate
5.3 Global Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Consumption and Value Forecast by Application
5.3.1 Global Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Consumption Forecast by Application 2021-2026
5.3.2 Global Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Market Value Forecast by Application 2021-2026
5.4 Global Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Market Consumption, Value and Growth Rate by Application Forecast 2021-2026
5.4.1 Oncology Market Consumption, Value and Growth Rate Forecast
5.4.2 Neurological Disorders Market Consumption, Value and Growth Rate Forecast
5.4.3 Cardiovascular Disease Market Consumption, Value and Growth Rate Forecast
5.4.4 Immunological Disorders Market Consumption, Value and Growth Rate Forecast
5.4.5 Others Market Consumption, Value and Growth Rate Forecast

6 Global Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) by Region, Historical Data and Market Forecasts
6.1 Global Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Sales by Region 2016-2021
6.2 Global Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Market Value by Region 2016-2021
6.3 Global Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Market Sales, Value and Growth Rate by Region 2016-2021
6.3.1 North America
6.3.2 Europe
6.3.3 Asia Pacific
6.3.4 South America
6.3.5 Middle East and Africa
6.4 Global Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Sales Forecast by Region 2021-2026
6.5 Global Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Market Value Forecast by Region 2021-2026
6.6 Global Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Market Sales, Value and Growth Rate Forecast by Region 2021-2026
6.6.1 North America
6.6.2 Europe
6.6.3 Asia Pacific
6.6.4 South America
6.6.5 Middle East and Africa

7 United State Market Size Analysis 2016-2026
7.1 United State Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Value and Market Growth 2016-2021
7.2 United State Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Sales and Market Growth 2016-2021
7.3 United State Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Market Value Forecast 2021-2026

8 Canada Market Size Analysis 2016-2026
8.1 Canada Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Value and Market Growth 2016-2021
8.2 Canada Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Sales and Market Growth 2016-2021
8.3 Canada Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Market Value Forecast 2021-2026

9 Germany Market Size Analysis 2016-2026
9.1 Germany Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Value and Market Growth 2016-2021
9.2 Germany Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Sales and Market Growth 2016-2021
9.3 Germany Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Market Value Forecast 2021-2026

10 UK Market Size Analysis 2016-2026
10.1 UK Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Value and Market Growth 2016-2021
10.2 UK Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Sales and Market Growth 2016-2021
10.3 UK Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Market Value Forecast 2021-2026

11 France Market Size Analysis 2016-2026
11.1 France Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Value and Market Growth 2016-2021
11.2 France Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Sales and Market Growth 2016-2021
11.3 France Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Market Value Forecast 2021-2026

12 Italy Market Size Analysis 2016-2026
12.1 Italy Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Value and Market Growth 2016-2021
12.2 Italy Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Sales and Market Growth 2016-2021
12.3 Italy Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Market Value Forecast 2021-2026

13 Spain Market Size Analysis 2016-2026
13.1 Spain Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Value and Market Growth 2016-2021
13.2 Spain Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Sales and Market Growth 2016-2021
13.3 Spain Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Market Value Forecast 2021-2026

14 Russia Market Size Analysis 2016-2026
14.1 Russia Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Value and Market Growth 2016-2021
14.2 Russia Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Sales and Market Growth 2016-2021
14.3 Russia Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Market Value Forecast 2021-2026

15 China Market Size Analysis 2016-2026
15.1 China Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Value and Market Growth 2016-2021
15.2 China Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Sales and Market Growth 2016-2021
15.3 China Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Market Value Forecast 2021-2026

16 Japan Market Size Analysis 2016-2026
16.1 Japan Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Value and Market Growth 2016-2021
16.2 Japan Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Sales and Market Growth 2016-2021
16.3 Japan Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Market Value Forecast 2021-2026

17 South Korea Market Size Analysis 2016-2026
17.1 South Korea Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Value and Market Growth 2016-2021
17.2 South Korea Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Sales and Market Growth 2016-2021
17.3 South Korea Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Market Value Forecast 2021-2026

18 Australia Market Size Analysis 2016-2026
18.1 Australia Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Value and Market Growth 2016-2021
18.2 Australia Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Sales and Market Growth 2016-2021
18.3 Australia Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Market Value Forecast 2021-2026

19 Thailand Market Size Analysis 2016-2026
19.1 Thailand Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Value and Market Growth 2016-2021
19.2 Thailand Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Sales and Market Growth 2016-2021
19.3 Thailand Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Market Value Forecast 2021-2026

20 Brazil Market Size Analysis 2016-2026
20.1 Brazil Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Value and Market Growth 2016-2021
20.2 Brazil Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Sales and Market Growth 2016-2021
20.3 Brazil Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Market Value Forecast 2021-2026

21 Argentina Market Size Analysis 2016-2026
21.1 Argentina Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Value and Market Growth 2016-2021
21.2 Argentina Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Sales and Market Growth 2016-2021
21.3 Argentina Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Market Value Forecast 2021-2026

22 Chile Market Size Analysis 2016-2026
22.1 Chile Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Value and Market Growth 2016-2021
22.2 Chile Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Sales and Market Growth 2016-2021
22.3 Chile Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Market Value Forecast 2021-2026

23 South Africa Market Size Analysis 2016-2026
23.1 South Africa Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Value and Market Growth 2016-2021
23.2 South Africa Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Sales and Market Growth 2016-2021
23.3 South Africa Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Market Value Forecast 2021-2026

24 Egypt Market Size Analysis 2016-2026
24.1 Egypt Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Value and Market Growth 2016-2021
24.2 Egypt Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Sales and Market Growth 2016-2021
24.3 Egypt Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Market Value Forecast 2021-2026

25 UAE Market Size Analysis 2016-2026
25.1 UAE Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Value and Market Growth 2016-2021
25.2 UAE Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Sales and Market Growth 2016-2021
25.3 UAE Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Market Value Forecast 2021-2026

26 Saudi Arabia Market Size Analysis 2016-2026
26.1 Saudi Arabia Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Value and Market Growth 2016-2021
26.2 Saudi Arabia Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Sales and Market Growth 2016-2021
26.3 Saudi Arabia Pharmacogenomics Technology/ Theranostics/ Companion Diagnostics (CDx) Market Value Forecast 2021-2026

27 Market Dynamic Analysis and Development Suggestions
27.1 Market Drivers
27.2 Market Development Constraints
27.3 PEST Analysis
27.3.1 Political Factors
27.3.2 Economic Factors
27.3.3 Social Factors
27.3.4 Technological Factors
27.4 Industry Trends Under COVID-19
27.4.1 Risk Assessment on COVID-19
27.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
27.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
27.5 Market Entry Strategy Analysis
27.5.1 Market Definition
27.5.2 Client
27.5.3 Distribution Model
27.5.4 Product Messaging and Positioning
27.5.5 Price
27.6 Advice on Entering the Market